These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12176532)

  • 1. Calcineurin inhibitor-free immunosuppressive regimen for marginal donors/recipients of kidney transplantation.
    Donati D; Ambrosini A; Marconi A; Mazzola E
    Transplant Proc; 2002 Aug; 34(5):1678-80. PubMed ID: 12176532
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of a calcineurin-inhibitor-free immunosuppressive protocol in renal transplant recipients of expanded criteria deceased donors.
    Re LS; Rial MC; Guardia OE; Galdo MT; Casadei DH
    Transplant Proc; 2006 Dec; 38(10):3468-9. PubMed ID: 17175306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results.
    Tullius SG; Pratschke J; Strobelt V; Kahl A; Reinke P; May G; Frei U; Neuhaus P
    Transplant Proc; 2003 Sep; 35(6):2100-1. PubMed ID: 14529854
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcineurin inhibitor-free immunosuppressive strategy in elderly recipients of renal allografts from deceased donors: 1-year results from a prospective single center trial.
    Arbogast HP; Hoffmann JN; Illner WD; Hillebrand GF; Fischereder M; Jauch KW; Land W
    Transplant Proc; 2009; 41(6):2529-32. PubMed ID: 19715968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids.
    Charpentier B
    Transplant Proc; 2001 Jun; 33(4 Suppl):3S-10S. PubMed ID: 11406262
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.
    Charpentier B
    Transplant Proc; 2001; 33(7-8):3334-6. PubMed ID: 11750425
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of early versus delayed calcineurin inhibitor treatment on delayed graft function.
    Ruiz MC; Ruiz N; Castilla M; Asensio C; Bravo J; Osuna A
    Transplant Proc; 2003 Mar; 35(2):692-4. PubMed ID: 12644096
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcineurin inhibitor-free immunosuppression in dual kidney transplantation from elderly donors.
    Furian L; Baldan N; Margani G; Ekser B; Silvestre C; Marchini F; Bonfante L; Rossi B; Valente ML; Rigotti P
    Clin Transplant; 2007; 21(1):57-62. PubMed ID: 17302592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
    Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
    Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of antithymocyte globulin induction treatment on renal transplant outcome.
    Sanchez-Fructuoso AI; Naranjo P; Torrente J; Fernández-Pérez C; Avilés B; Prats D; Barrientos A
    Transplant Proc; 1998 Aug; 30(5):1790-2. PubMed ID: 9723284
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial.
    Guba M; Pratschke J; Hugo C; Krämer BK; Nohr-Westphal C; Brockmann J; Andrassy J; Reinke P; Pressmar K; Hakenberg O; Fischereder M; Pascher A; Illner WD; Banas B; Jauch KW;
    Transplantation; 2010 Jul; 90(2):175-83. PubMed ID: 20463641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of delayed graft function on cadaveric kidney transplant outcome.
    Gentil MA; Alcaide MP; Algarra GR; Pereira P; Toro J; González-Roncero F; López M; Bernal G; Mateos J
    Transplant Proc; 2003 Mar; 35(2):689-91. PubMed ID: 12644095
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcineurin inhibitors are not antagonistic to tolerance induction.
    Cosimi AB
    Transplant Proc; 2002 Aug; 34(5):1376-7. PubMed ID: 12176403
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing incidence of steroid resistant rejection in kidney transplantation.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
    Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
    Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the graft survival in cadaver donor kidney transplantation.
    Chon SE; Lee KW; Joh JW; Kim SJ; Park JH; Lee SK; Oh HY; Huh WS; Kim YI; Lee BB
    Transplant Proc; 2003 Feb; 35(1):147-8. PubMed ID: 12591342
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal transplantation in Iran: a single-center study.
    Kayedi M; Golbabaie M; Najafi I; Ganji MR; Naderi GH; Mehraban D; Hakemi M
    Transplant Proc; 2001 Aug; 33(5):2646-7. PubMed ID: 11498104
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of low-dose calcineurin inhibitors on acute rejection and graft survival.
    Altaca G; Berber I; Aydin C; Titiz I
    Transplant Proc; 2002 Sep; 34(6):2079-80. PubMed ID: 12270320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.